跳至主要内容
临床试验/KCT0001713
KCT0001713已完成未知

Development of technology for robust production of latent virus specific cytotoxic T lymphocytes

The Catholic University of Korea, Seoul St. Mary's Hospital0 个研究点目标入组 5 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
20(Year) 至 75(Year)(—)
性别
All

入选标准

  • Inclusion criteria include:
  • 1. Signed informed consent form approved by the KCMC IRB.
  • 2. Age 20 to 75 years,

排除标准

  • 1. Unable to provide informed consent
  • 2. Ages under 20 or over 75
  • 3. HIV positive individuals or either HBV or HCV positive individuals
  • 4. Individuals with systemic or active infections requiring medical attention
  • 5. Individuals who had previously participated in a blood donation of 200mL to 400mL within the past three months

研究者

发起方
The Catholic University of Korea, Seoul St. Mary's Hospital

相似试验